These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 28738249

  • 1. New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability.
    Abd-Ellah HS, Abdel-Aziz M, Shoman ME, Beshr EAM, Kaoud T, Ahmed AFF.
    Bioorg Chem; 2017 Oct; 74():15-29. PubMed ID: 28738249
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
    Banerjee AG, Das N, Shengule SA, Srivastava RS, Shrivastava SK.
    Eur J Med Chem; 2015 Aug 28; 101():81-95. PubMed ID: 26117820
    [Abstract] [Full Text] [Related]

  • 4. Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability.
    Abdelgawad MA, Bakr RB, Azouz AA.
    Bioorg Chem; 2018 Apr 28; 77():339-348. PubMed ID: 29421710
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
    Palkar MB, Singhai AS, Ronad PM, Vishwanathswamy AH, Boreddy TS, Veerapur VP, Shaikh MS, Rane RA, Karpoormath R.
    Bioorg Med Chem; 2014 May 15; 22(10):2855-66. PubMed ID: 24751552
    [Abstract] [Full Text] [Related]

  • 6. New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies.
    Abdellatif KRA, Abdelall EKA, Elshemy HAH, El-Nahass ES, Abdel-Fattah MM, Abdelgawad YYM.
    Arch Pharm (Weinheim); 2021 Apr 15; 354(4):e2000328. PubMed ID: 33314237
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and molecular docking of benzophenone conjugated with oxadiazole sulphur bridge pyrazole pharmacophores as anti inflammatory and analgesic agents.
    Zabiulla, Gulnaz AR, Mohammed YHE, Khanum SA.
    Bioorg Chem; 2019 Nov 15; 92():103220. PubMed ID: 31493708
    [Abstract] [Full Text] [Related]

  • 8. Novel 4-methylsulfonylphenyl derivatives as NSAIDS with preferential COX-2 inhibition.
    Amin NH, Mohammed AA, Abdellatif KR.
    Future Med Chem; 2018 Jan 15; 10(1):53-70. PubMed ID: 29235887
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity.
    Halim PA, Georgey HH, George MY, El Kerdawy AM, Said MF.
    Bioorg Chem; 2021 Oct 15; 115():105253. PubMed ID: 34390973
    [Abstract] [Full Text] [Related]

  • 11. Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations.
    Mohassab AM, Hassan HA, Abdelhamid D, Abdel-Aziz M, Dalby KN, Kaoud TS.
    Bioorg Chem; 2017 Dec 15; 75():242-259. PubMed ID: 29032325
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Design, synthesis and anti-inflammatory assessment of certain substituted 1,2,4-triazoles bearing tetrahydroisoquinoline scaffold as COX 1/2-inhibitors.
    Abo-Elmagd MI, Hassan RM, Aboutabl ME, Amin KM, El-Azzouny AA, Aboul-Enein MN.
    Bioorg Chem; 2024 Sep 15; 150():107577. PubMed ID: 38941697
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles.
    Faidallah HM, Rostom SAF.
    Arch Pharm (Weinheim); 2017 May 15; 350(5):. PubMed ID: 28370254
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.
    Bakr RB, Azouz AA, Abdellatif KR.
    J Enzyme Inhib Med Chem; 2016 May 15; 31(sup2):6-12. PubMed ID: 27210522
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
    Khalil NA, Ahmed EM, Mohamed KO, Nissan YM, Zaitone SA.
    Bioorg Med Chem; 2014 Apr 01; 22(7):2080-9. PubMed ID: 24631365
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study.
    Abdel-Aziz AA, El-Azab AS, AlSaif NA, Alanazi MM, El-Gendy MA, Obaidullah AJ, Alkahtani HM, Almehizia AA, Al-Suwaidan IA.
    J Enzyme Inhib Med Chem; 2020 Dec 01; 35(1):610-621. PubMed ID: 32013633
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.